Key result
Biomarkers in systemic arterial hypertension and related disorders may provide a non-invasive approach for diagnosis, prognosis, risk assessment, and therapy management to improve patient outcomes.
Why the study?
Early and precise recognition of systemic arterial hypertension is critical to prevent secondary cardiovascular and renal diseases, and biomarkers may aid in diagnosing and predicting these conditions.
Biomarkers may provide a non-invasive approach for the diagnosis, prognosis, and management of systemic arterial hypertension and its related cardiovascular and renal complications.
May support biomarker-guided hypertension care; leaves open prospective validation before clinical adoption.
Systemic arterial hypertension (SAH) is a major risk factor for several secondary diseases, especially cardiovascular and renal conditions. SAH has a high prevalence worldwide, and its precise and early recognition is important to prevent the development of secondary outcomes. In this field, the study of biomarkers represents an important approach to diagnosing and predicting the disease and its associated conditions. The use of biomarkers in hypertension and hypertension-related disorders, such as ischemic stroke, intracerebral hemorrhage, transient ischemic attack, acute myocardial infarction, angina pectoris and chronic kidney disease, are discussed in this review. Establishing a potential pool of biomarkers may contribute to a non-invasive and improved approach for their diagnosis, prognosis, risk assessment, therapy management and pharmacological responses to a therapeutic intervention to improve patients' quality of life and prevent unfavorable outcomes.
No takes yet. Share an insight, caveat, or question.
Ribeiro et al. (2022) conducted a review in Systemic arterial hypertension and hypertension-related disorders. Biomarkers was evaluated. Biomarkers in systemic arterial hypertension and related disorders may provide a non-invasive approach for diagnosis, prognosis, risk assessment, and therapy management to improve patient outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: